港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点

智通财经2025-05-06

【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533655271?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-06 23:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533655271","market":"sh","top_or_hot":-1,"title":"港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点","media":"智通财经","content":"<div>\n<p>【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289893.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-06 23:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1289893.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289893.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00512","symbol_name":"远大医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1289893.html","article_id":"2533655271","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533655271","pubTimestamp":1746543685,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"00512":"远大医药","YANG":"三倍做空富时中国ETF-Direxion","HSTECH":"恒生科技指数","BK1231":"综合性银行","HSHD.SI":"HSBC HK SDR 5to1","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","00656":"复星国际","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","03143":"华夏香港银行股","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","BK1572":"香港银行股","BK4614":"Manus概念股","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","BK1610":"ETF&股票定投概念","BK1191":"制药","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","HSBC":"汇丰","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","HSBA.UK":"汇丰控股有限公司","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","BK1230":"工业集团企业","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","BK1601":"香港本地股","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","HSCEI":"国企指数","00005":"汇丰控股"},"translate_title":"Hong Kong stock announcement Nuggets Grand Pharmaceutical's global innovative product STC3141 successfully reached the clinical endpoint in phase II clinical study in China for the treatment of sepsis","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YANG":1,"HSCEI":1,"03143":0.6,"HSTECH":1,"HSBC":0.6,"HSBA.UK":0.6,"00005":0.9,"00512":1,"HSHD.SI":0.6,"00656":0.9},"content_text":"【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作【财务数据】：德视佳(01846)一季度进行的眼科手术总数为6997例，同比减少约3%富智康集团(02038)一季度溢利107.2万美元，同比扭亏为盈【股份回购】：汇丰控股(00005)拟回购总值最多30亿美元股份","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533655271","isCrawlerRequest":true}